ImmuPharma PLC

ImmuPharma PLC
Stock Exchange London Stock Exchange
EPS
GBP0.05
Market Cap
GBP14.71 M
Shares Outstanding
139.47 M
Public Float
102.98 M

Profile

Address
50 Broadway
London Greater London SW1 H0RG
United Kingdom
Employees -
Website http://www.immupharma.com
Updated 07/08/2019
ImmuPharma Plc engages in the research, development, and commercialisation of pharmaceutical products. Its drug candidate, Lupuzor, is a potential treatment for the autoimmune chronic inflammatory disease lupus. The company was founded by Richard Warr and Dimitri F.

Financials

View All

Dimitri F. Dimitriou
Chief Executive Officer & Director
Robert Henri Zimmer
President, Director & Chief Scientific Officer